New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
On January 3, 2022, the FDA announced expanded emergency use authorization (EUA) for the Pfizer/BioNTech COVID-19 vaccine.
Download PDF
Return to publications
